The global demand for Gastric Cancer Market is presumed to reach the market size of nearly USD 15.77 BN by 2030 from USD 4.14 BN in 2022 with a CAGR of 18.21% under the study period 2023 - 2030.
Gastric cancer, also known as stomach cancer, is a type of cancer that develops in the cells lining the stomach. It is a relatively common form of cancer and can occur in any part of the stomach. It often develops slowly over several years, and the early stages may not cause noticeable symptoms, making it challenging to diagnose in its early stages.
The increasing prevalence of gastric cancer globally, particularly in developing countries, is a major driver. Factors such as changing dietary patterns, tobacco and alcohol consumption, and chronic Helicobacter pylori infections contribute to its rising incidence. Advancements in diagnostic technologies, including endoscopy, CT scans, MRI, and molecular testing, have improved early detection and accurate diagnosis of gastric cancer, leading to increased demand for diagnostic tools. The treatment landscape has evolved with advancements in surgical techniques, chemotherapy, radiation therapy, targeted therapy, and immunotherapy. The development of targeted therapies, personalized treatment approaches, and ongoing research and development efforts contribute to market growth. Supportive healthcare policies, government initiatives, and awareness campaigns promote early detection, prevention, and treatment of gastric cancer. The ageing population, with its higher susceptibility to this condition, also drives the market. International collaborations, standardized guidelines, and knowledge sharing play a crucial role in improving treatment outcomes and driving market growth.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of gastric cancer. The growth and trends of gastric cancer industry provide a holistic approach to this study.
This section of the gastric cancer market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Disease Type
By Treatment Type
By Drug Class
By Route Of Administration
By Distribution Channel
This section covers the regional outlook, which accentuates current and future demand for the Gastric Cancer market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the gastric cancer market include Novartis AG, Merck & Co., Inc., Celltrion Healthcare Co., Ltd., samsung bioepis, Teva Pharmaceutical Industries Ltd., Mylan N.V., Bristol Myers Squibb Company, F. Hoffmann La Roche Ltd., Pfizer, Inc., Eli Lilly. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
1 . PREFACE
1.1. Report Description
1.1.1. Objective
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of Market
2.2. Global Market Snapshot
3 . GASTRIC CANCER – INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter’s Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 Market Attractiveness Analysis By Disease Type
3.7.2 Market Attractiveness Analysis By Treatment Type
3.7.3 Market Attractiveness Analysis By Drug Class
3.7.4 Market Attractiveness Analysis By Route Of Administration
3.7.5 Market Attractiveness Analysis By Distribution Channel
3.7.6 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Raw Material Manufactures List
4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 . GLOBAL GASTRIC CANCER MARKET ANALYSIS BY DISEASE TYPE
5.1 Overview by Disease Type
5.2 Historical and Forecast Data
5.3 Analysis by Disease Type
5.4 Adenocarcinoma Historic and Forecast Sales by Regions
5.5 Lymphoma Historic and Forecast Sales by Regions
5.6 Gastrointestinal Stromal Tumor Historic and Forecast Sales by Regions
5.7 Carcinoid Tumor Historic and Forecast Sales by Regions
5.8 Others Historic and Forecast Sales by Regions
6 . GLOBAL GASTRIC CANCER MARKET ANALYSIS BY TREATMENT ...